Among the signaling molecules involved in the regulation of Akt isozymes in breast tumors, a crucial role was recently demonstrated for Vav1, a multidomain protein physiologically expressed in hematopoietic cells, in which it regulates cytoskeleton reorganization, gene transcription and miRNAs expression [16,17,18]. The gene discussed is AKT1; the disease is breast neoplasm.